Marktanalyse - OTC Pharmaceuticals in Egypt

Introduction

OTC Pharmaceuticals in Egypt industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2006-10, and forecast to 2015). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Egypt otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights

*The over-the-counter (OTC) pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirin and other analgesics), and medicated skin products (anti-bacteria’s, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness). The market is valued according to retail selling price (RSP) and includes any applicable taxes. Any currency conversions used in the creation of this report have been calculated using constant 2010 annual average exchange rates.

*The Egyptian OTC pharmaceuticals market generated total revenues of $680.5 million in 2010, representing a compound annual growth rate (CAGR) of 7.1% for the period spanning 2006-2010.

*Analgesics sales proved the most lucrative for the Egyptian OTC pharmaceuticals market in 2010, generating total revenues of $163.1 million, equivalent to 24% of the market's overall value.

*The performance of the market is forecast to decelerate, with an anticipated CAGR of 5.4% for the five-year period 2010-2015, which is expected to lead the market to a value of $885.4 million by the end of 2015.

Features

Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the otc pharmaceuticals market in Egypt

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the otc pharmaceuticals market in Egypt

Leading company profiles reveal details of key otc pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Egypt otc pharmaceuticals market with five year forecasts by both value and volume

Macroeconomic indicators provide insight into general trends within the Egypt economy

Key Questions Answered

What was the size of the Egypt otc pharmaceuticals market by value in 2010?

What will be the size of the Egypt otc pharmaceuticals market in 2015?

What factors are affecting the strength of competition in the Egypt otc pharmaceuticals market?

How has the market performed over the last five years?

Who are the top competitiors in Egypt's otc pharmaceuticals market?

TABLE OF CONTENTS

EXECUTIVE SUMMARY 2

MARKET OVERVIEW 6

Market definition 6

Market analysis 6

MARKET DATA 7

Market value 7

MARKET SEGMENTATION 8

Category segmentation 8

Geography segmentation 10

Market share 11

Market distribution 12

MARKET OUTLOOK 13

Market value forecast 13

FIVE FORCES ANALYSIS 14

Summary 14

Buyer power 15

Supplier power 16

New entrants 17

Threat of substitutes 18

Degree of rivalry 19

LEADING COMPANIES 20

GlaxoSmithKline Plc. 20

Johnson & Johnson 23

Amoun Pharmaceuticals Co 27

MACROECONOMIC INDICATORS 28

Country Data 28

APPENDIX 30

Methodology 30

Industry associations 31

Related MarketLine research 31



LIST OF TABLES

Table 1: Egypt OTC pharmaceuticals market value: $ million, 2006—10 7

Table 2: Egypt OTC pharmaceuticals market category segmentation : % share, by value, 2006 - 2010 8

Table 3: Egypt OTC pharmaceuticals market category segmentation : $million, by value, 2006 - 2010 8

Table 4: Egypt OTC pharmaceuticals market geography segmentation, by value, 2010 10

Table 5: Egypt OTC pharmaceuticals market share: % share, by value, 2010 11

Table 6: Egypt OTC pharmaceuticals market distribution: % share, by value, 2010 12

Table 7: Egypt OTC pharmaceuticals market value forecast: $ million, 2010—15 13

Table 8: GlaxoSmithKline Plc.: key facts 20

Table 9: GlaxoSmithKline Plc.: key financials ($) 21

Table 10: GlaxoSmithKline Plc.: key financials (£) 21

Table 11: GlaxoSmithKline Plc.: key financial ratios 21

Table 12: Johnson & Johnson: key facts 23

Table 13: Johnson & Johnson: key financials ($) 24

Table 14: Johnson & Johnson: key financial ratios 25

Table 15: Amoun Pharmaceuticals Co: key facts 27

Table 16: Egypt size of population (million), 2006—10 28

Table 17: Egypt GDP (constant 2000 prices, $ billion), 2006—10 28

Table 18: Egypt GDP (current prices, $ billion), 2006—10 28

Table 19: Egypt inflation, 2006—10 29

Table 20: Egypt consumer price index (absolute), 2006—10 29

Table 21: Egypt exchange rate, 2006—10 29



LIST OF FIGURES

Figure 1: Egypt OTC pharmaceuticals market value: $ million, 2006—10 7

Figure 2: Egypt OTC pharmaceuticals market category segmentation : $million, by value, 2006 - 2010 9

Figure 3: Egypt OTC pharmaceuticals market geography segmentation : % share, by value, 2010 10

Figure 4: Egypt OTC pharmaceuticals market share: % share, by value, 2010 11

Figure 5: Egypt OTC pharmaceuticals market distribution: % share, by value, 2010 12

Figure 6: Egypt OTC pharmaceuticals market value forecast: $ million, 2010—15 13

Figure 7: Forces driving competition in the OTC pharmaceuticals market in Egypt, 2010 14

Figure 8: Drivers of buyer power in the OTC pharmaceuticals market in Egypt, 2010 15

Figure 9: Drivers of supplier power in the OTC pharmaceuticals market in Egypt, 2010 16

Figure 10: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Egypt, 2010 17

Figure 11: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Egypt, 2010 18

Figure 12: Drivers of degree of rivalry in the OTC pharmaceuticals market in Egypt, 2010 19

Figure 13: GlaxoSmithKline Plc.: revenues & profitability 22

Figure 14: GlaxoSmithKline Plc.: assets & liabilities 22

Figure 15: Johnson & Johnson: revenues & profitability 25

Figure 16: Johnson & Johnson: assets & liabilities 26

• OTC Triptans in Azerbaijan
• Calming and Sleeping in Australia
• Calming and Sleeping in Croatia
• Cough, Cold and Allergy (Hay Fever) Remedies in Australia
• Cough, Cold and Allergy (Hay Fever) Remedies in Croatia
• Over-the-counter Pharmaceuticals Market in the Asia Pacific Region 2012-2016
• Over-the-counter Pharmaceuticals Market in the Asia Pacific Region 2012-2016
• Global Over-the-counter Pharmaceutical Market 2012-2016
• OTC Pharmaceuticals and Self-medication in Seven Emerging Markets
• OTC Triptans in Germany
• OTC Triptans in Sweden
• OTC Triptans in the United Kingdom
• Cough, Cold and Allergy (Hay Fever) Remedies in the US
• Rx-to-OTC Switching Strategies - New Switching Opportunities in Weight Management and Smoking Cessation, but Encouraging the Uptake of Self-Medication Remains a Challenge
• Global OTC Pharmaceuticals
• OTC Pharmaceuticals - BRIC (Brazil, Russia, India, China) Industry Guide
• OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide
• OTC Pharmaceuticals - North America (NAFTA) Industry Guide
• OTC Pharmaceuticals - Scandinavia Industry Guide
• OTC Pharmaceuticals - Top 5 Emerging Markets Industry Guide